Login

Philip Toleikis, Ph.D., CEO and President, Sernova Corp 00:00:00

Share On Facebook Share On Twitter

Philip Toleikis, Ph.D., CEO and President, Sernova Corp

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Judicial Fortitude: Reining in the Administrative State|Peter Wallison
00:10:00
Meet our investors : Valar Ventures|Andrew McCormack,General Partner,Valar Ventures
00:10:00
Alzamend Neuro is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease|Stephan Jackman , Chief Executive Officer at Alzamend Neuro
00:10:00
AAK AB Q4 and Year-End 2023 Report: Insights from CEO Johan Westman | Johan Westman, CEO , AAK AB.
00:10:00
support early-stage startups as they need|Garrett Camp,Founding Partner,Expa
00:10:00
Gladiator Gold: Aggressive Exploration Campaign at One-to-One Mining Conference in London
00:00:00
Silvi Rouskin Assistant Professor of Microbiology, HMS
00:10:00
leveraging science and technology in service of achieving the UN’s Sustainable Development|Wes Selke,Founder and Managing Director,Better Ventures
00:10:00
Will Marshall, co-founder and CEO of Planet Labs, discusses the company's going public via SPAC on 'Squawk on the Street'.|Will Marshall, co-founder & CEO of Planet Labs,
00:10:00
CEO Talks with Luc Vandenbulcke, CEO of DEME | Luc Vandenbulcke - CEO of DEME
00:10:00
PETER STEENKAMP CEO of Harmony Gold Mining Company Limited, discusses company developments at the Precious Metals Summit 2019, with forward-looking statements cautioning viewers to refer to periodic filings for comprehensive information.|Phillip Tobias,
00:10:00
Lucas Lundin: Bullish on Copper, Gold, and Uranium for the Future

© 2017 - Neuhu+